Indunil Karunarathna on CSF Xanthochromia in SAH
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), shared on LinkedIn:
”Xanthochromia in Cerebrospinal Fluid Diagnostic Relevance, and Implications in Subarachnoid Hemorrhage
Uva Clinical Research Lab 2025, Uva Clinical Anaesthesia and Intensive Care ISSN 2827-7198, 2025
Xanthochromia refers to the yellowish discoloration of cerebrospinal fluid (CSF) due to the presence of bilirubin—a breakdown product of hemoglobin resulting from the lysis of red blood cells in the subarachnoid space.
This clinical finding holds paramount diagnostic significance, particularly in the context of suspected subarachnoid hemorrhage (SAH), where imaging may be inconclusive.
Xanthochromia typically becomes detectable within 6 to 12 hours after hemorrhage and may persist for up to four weeks, offering a critical window for diagnosis when radiologic modalities fail.
This comprehensive review elucidates the etiology, epidemiology, pathophysiology, histopathological basis, and clinical evaluation of xanthochromia.
Etiologically, while SAH is the most clinically urgent cause, other contributors include neoplasms, infections, and systemic hyperbilirubinemia.
The visual detection of xanthochromia remains common, but spectrophotometry provides superior sensitivity and specificity, allowing precise differentiation of bilirubin from other pigments such as oxyhemoglobin.
The integration of lumbar puncture and CSF analysis into the diagnostic algorithm remains indispensable, especially after a negative noncontrast CT scan in patients presenting with thunderclap headaches or other SAH-compatible symptoms.
A multidisciplinary approach involving emergency physicians, neurologists, neurosurgeons, radiologists, and laboratory technicians is vital to ensure accurate diagnosis and timely treatment, particularly in the context of aneurysmal rupture.
Understanding the nuances of xanthochromia enhances diagnostic accuracy, minimizes unnecessary interventions, and improves patient outcomes in neurologic emergencies.”
Read the full article here.
Article: Xanthochromia in Cerebrospinal Fluid Diagnostic Relevance, and Implications in Subarachnoid Hemorrhage
Author: Indunil Karunarathna
Stay updated with Hemostasis Today.
-
Oct 15, 2026, 18:26Chanakya Nayudu: Presenting My Research at ISTH Congress 2026 in Paris
-
Oct 15, 2026, 18:09Maha Othman: Students Lead World Thrombosis Day 2026 Awareness Events
-
Oct 15, 2026, 17:52Jill de Mol։ Rapamycin Modulates Immune Responses in Aged Atherosclerosis
-
Oct 15, 2026, 17:41Victor Aboyans։ Think About Lipids in VTE
-
Oct 15, 2026, 17:08Babu Mia։ Targeting PPM1D to Eliminate Malignant Stem Cells in Myeloproliferative Neoplasms
-
Oct 15, 2026, 16:26Hauke Horstmann: Can an Existing Drug Be Repurposed to Treat Atherosclerosis?
-
Oct 15, 2026, 15:19Bernadette Borrelli: AdventHealth Teams Unite to Mark World Thrombosis Day
-
Oct 15, 2026, 15:03Mohamed Magdy: The Hematological Consequences of Portal Hypertension in Banti Syndrome
-
Oct 15, 2026, 14:34Marium Khan: New Systematic Review Examines Asundexian Safety and Efficacy in Cardiovascular Disease